宪康 方 is a Senior Director of Pharmacology with extensive experience in preclinical pharmacology research. They served as Director of in vivo pharmacology at Structure Therapeutics from 2021 to 2023 and held various scientist roles in notable organizations including Eli Lilly China and WuXi AppTec. They completed their postdoctoral studies in Pharmacology at 复旦大学 from 2010 to 2012.宪康方 exhibits strong analytical capabilities and leadership skills, successfully coordinating teams to achieve project goals and providing timely data reports throughout their career.
This person is not in any teams
This person is not in any offices